申请人:Cao Jianguo
公开号:US20060247250A1
公开(公告)日:2006-11-02
The invention provides pyrimidine compounds having formula A. The pyrimidine compounds of the invention are capable of inhibiting kinases, such as members of the Src kinase family, and various other specific receptor and non-receptor kinases.
本发明提供了具有A式的嘧啶化合物。本发明的嘧啶化合物能够抑制激酶,例如Src激酶家族成员和各种其他特定的受体和非受体激酶。